mRECIST and EASL responses at early time point by contrast-enhanced dynamic MRI predict survival in patients with unresectable hepatocellular carcinoma (HCC) treated by doxorubicin drug-eluting beads transarterial chemoembolization (DEB TACE)
Author:
Publisher
Elsevier BV
Subject
Oncology,Hematology
Link
http://academic.oup.com/annonc/article-pdf/24/4/965/13789292/mds605.pdf
Reference31 articles.
1. Primary liver cancer: worldwide incidence and trends;Bosch;Gastroenterology,2004
2. Global cancer statistics, 2002;Parkin;CA Cancer J Clin,2005
3. Hepatocellular carcinoma incidence, mortality, and survival trends in the United States from 1975 to 2005;Altekruse;J Clin Oncol,2009
4. Treatment modalities for hepatocellular carcinoma;Hung;Curr Cancer Drug Targets,2005
5. Comparison of conventional transarterial chemoembolization (TACE) and chemoembolization with doxorubicin drug eluting beads (DEB) for unresectable hepatocelluar carcinoma (HCC);Dhanasekaran;J Surg Oncol,2010
Cited by 106 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Multidisciplinary assessment of tumor response after internal and external radiation therapy for hepatocellular carcinoma;Hepatoma Research;2024-07-24
2. Defining a radiomics feature selection method for predicting response to transarterial chemoembolization in hepatocellular carcinoma patients;Meta-Radiology;2024-03
3. Prediction of initial objective response to drug-eluting beads transcatheter arterial chemoembolization for hepatocellular carcinoma using CT radiomics-based machine learning model;Frontiers in Pharmacology;2024-01-25
4. Early post-treatment MRI predicts long-term hepatocellular carcinoma response to radiation segmentectomy;European Radiology;2023-08-04
5. Development and Validation of a Model including Arterial Enhancement Fraction to Predict the Progression in HCC Patients Undergoing Chemoembolization;2023-04-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3